Her2 and TGFBeta CTLs in Treatment of Her2 Positive Malignancy (HERCREEM)
This study is currently recruiting participants.
Verified May 2013 by Baylor College of Medicine
Sponsor:
Baylor College of Medicine
Collaborators:
The Methodist Hospital System
Center for Cell and Gene Therapy, Baylor College of Medicine
Information provided by (Responsible Party):
Stephen Gottschalk, Baylor College of Medicine
ClinicalTrials.gov Identifier:
NCT00889954
First received: April 24, 2009
Last updated: May 11, 2013
Last verified: May 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | July 2030 |
| Estimated Primary Completion Date: | July 2015 (Final data collection date for primary outcome measure) |